CB Therapeutics
PrivateLast Round
Series A
May 10, 2021
Total Funding Raised
$370,000
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CB Therapeutics is a synthetic biology company that designs, develops, and manufactures high-value molecules through precision fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CB Therapeutics Comparables
Compare CB Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellibre | 87% | |
| Khona Scientific, Inc. | 83% | |
| Biomedican | 82% |
CB Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 10, 2021 | ||||
| Debt | May 3, 2020 | ||||
| Accelerator | Aug 1, 2018 | ||||
| Accelerator | Jul 25, 2017 |
Key People
Founding team and executive leadership
CB Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| re.Mind Capital | Series A |
| EvoNexus | Accelerator |
| 305 Ventures | Accelerator |
| Y Combinator | Accelerator |
| Healthspan Capital | Accelerator |
| Rebel Fund | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 479% MoM, from 259 to 1.5K.
CB Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CB Therapeutics's valuation, stock price, and market status.
Is CB Therapeutics a public or private company?
CB Therapeutics is a private company.
What is the current stock price of CB Therapeutics?
CB Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is CB Therapeutics worth (valuation)?
Valuation information for CB Therapeutics is not publicly available.
Can I buy CB Therapeutics stock?
CB Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CB Therapeutics's last funding round?
CB Therapeutics's most recent funding round was Series A on May 10, 2021.
Who are the main investors in CB Therapeutics?
Key investors in CB Therapeutics include re.Mind Capital.
Will CB Therapeutics IPO soon?
No public IPO plans have been announced for CB Therapeutics.
How can I track CB Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CB Therapeutics's secondary market activity and sign up for updates.